Investment analysis, share recommendations, and market insights.
My investment style seeks contrarian opportunities based on valuation, often during market corrections. While I don't feel like this is a 'buy-the-dip' scenario, I do think healthcare and consumer staples ETFs suit these uncertain times and here's why.
We went to air this week at the same time as President Trump held an address to the nation on Iran. Here's what happened live.
Michael Gable, Managing Director of Fairmont Equities, says he continues to believe we're seeing the start of a commodities bull market and investors can do well to rotate away from high P/E stocks, such as tech, and into hard assets, like Rio Tinto (RIO).
Raymond Chan, Adviser & Head of Asian Desk at Morgans, explains why Goodman Group (GMG) stands out as a buy.
Here are two of the ASX's most promising uranium-mining prospects – both with projects located in Africa, and each with different paths to market – that I think offer good buying, with certain caveats in mind.
Does the 'gold and guns' trade still have legs and is it a prime contrarian play to take advantage of current market weakness? Here's my view, with caveats.
Can I get $510,000 into super in the space of a couple of weeks? How can I follow the share price of Atlassian? What is the brokers target price for Xero? When is BOQ due to report?
With global conflict driving volatility, investors are questioning where to hide, or whether there’s anywhere to hide at all.
Given the unknowns, investors need to decide between defence and attack. If a faster resolution arrives, the stock market will rebound spectacularly.
The noise around rare earths has something going for it. Here is a speculative advanced developer to consider.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.